Clinical Research Directory
Browse clinical research sites, groups, and studies.
HPC Offered for PRESERVE Expansion
Sponsor: Ossium Health, Inc.
Summary
Ossium recognizes that not all patients who could benefit from Ossium's HPC, Marrow can access the PRESERVE trial for logistical or eligibility reasons. The HOPE program is expanded access program to serve these patients by providing our bone marrow product
Key Details
Gender
All
Age Range
12 Years - 80 Years
Study Type
OBSERVATIONAL
Enrollment
10
Start Date
2024-06-27
Completion Date
2029-08
Last Updated
2025-08-28
Healthy Volunteers
No
Conditions
Interventions
Bone Marrow Transplant with Ossium's HPC, Marrow (bone marrow recovered from deceased organ and tissue donors)
The HOPE Program does not include any investigational drugs. The medicines and procedures in this program are standard of care for a transplant. Bone marrow cells from a deceased organ and tissue donor for use in your transplant is the only product offered to you by Ossium Health.
Locations (4)
University of Alabama, Birmingham
Birmingham, Alabama, United States
Henry Ford Health
Detroit, Michigan, United States
The Ohio State University Medical Center
Columbus, Ohio, United States
Tristar Centennial Medical Center
Nashville, Tennessee, United States